Main Logo
+17162654855
[email protected]

Emerging Growth Patterns in Malaria Diagnostics Industry Market

Malaria Diagnostics Industry by Technology (Clinical Diagnostics, Microscopic Diagnostics, Rapid Diagnostic Tests (RDTs), Molecular Diagnostics, Other Technologies), by Americas (Venezuela, Brazil, Colombia, Rest of the Americas), by Europe (Germany, United Kingdom, France, Turkey, Spain, Rest of Europe), by Asia Pacific, by India (Myanmar, Indonesia, Pakistan, China, Papua New Guinea, Cambodia, Rest of Asia Pacific), by Africa (Democratic Republic of Congo, Nigeria, Uganda, Rest of Africa) Forecast 2026-2034

Base Year: 2025
234 Pages
Main Logo

Emerging Growth Patterns in Malaria Diagnostics Industry Market

About Precision Market View

Precision Market View offers precise market research, industry intelligence, and data analysis for healthcare, manufacturing, technology, and energy. Our reports provide the clarity you need to make informed decisions and drive growth.

Our team combines primary research, advanced analytics, and industry expertise to deliver actionable intelligence. We offer syndicated reports, custom research, and consulting services tailored to your business needs.

At Precision Market View, we are committed to quality, transparency, and client satisfaction. Every report is rigorously validated to ensure accuracy and relevance. Our global perspective and local expertise help you understand both the big picture and the finer details of your market.

Stay informed with Precision Market View. Subscribe to our newsletter for the latest updates and research highlights, and follow us on social media for real-time insights.

Precision Market View – Clarity for Your Strategic Decisions.

Geographic Coverage of Malaria Diagnostics Industry

Higher Coverage
Lower Coverage
No Coverage

Malaria Diagnostics Industry REPORT HIGHLIGHTS

AspectsDetails
Study Period 2020-2034
Base Year 2025
Estimated Year 2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 5.23% from 2020-2034
Segmentation
    • By Technology
      • Clinical Diagnostics
      • Microscopic Diagnostics
      • Rapid Diagnostic Tests (RDTs)
      • Molecular Diagnostics
      • Other Technologies
  • By Geography
    • Americas
      • Venezuela
      • Brazil
      • Colombia
      • Rest of the Americas
    • Europe
      • Germany
      • United Kingdom
      • France
      • Turkey
      • Spain
      • Rest of Europe
    • Asia Pacific
    • India
      • Myanmar
      • Indonesia
      • Pakistan
      • China
      • Papua New Guinea
      • Cambodia
      • Rest of Asia Pacific
    • Africa
      • Democratic Republic of Congo
      • Nigeria
      • Uganda
      • Rest of Africa

Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Objective
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Market Snapshot
  3. 3. Market Dynamics
    • 3.1. Market Drivers
    • 3.2. Market Restrains
    • 3.3. Market Trends
    • 3.4. Market Opportunities
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
      • 4.1.1. Bargaining Power of Suppliers
      • 4.1.2. Bargaining Power of Buyers
      • 4.1.3. Threat of New Entrants
      • 4.1.4. Threat of Substitutes
      • 4.1.5. Competitive Rivalry
    • 4.2. PESTEL analysis
    • 4.3. BCG Analysis
      • 4.3.1. Stars (High Growth, High Market Share)
      • 4.3.2. Cash Cows (Low Growth, High Market Share)
      • 4.3.3. Question Mark (High Growth, Low Market Share)
      • 4.3.4. Dogs (Low Growth, Low Market Share)
    • 4.4. Ansoff Matrix Analysis
    • 4.5. Supply Chain Analysis
    • 4.6. Regulatory Landscape
    • 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
    • 4.8. PMV Analyst Note
  5. 5. Market Analysis, Insights and Forecast 2021-2033
    • 5.1. Market Analysis, Insights and Forecast - by Technology
      • 5.1.1. Clinical Diagnostics
      • 5.1.2. Microscopic Diagnostics
      • 5.1.3. Rapid Diagnostic Tests (RDTs)
      • 5.1.4. Molecular Diagnostics
      • 5.1.5. Other Technologies
    • 5.2. Market Analysis, Insights and Forecast - by Region
      • 5.2.1. Americas
      • 5.2.2. Europe
      • 5.2.3. Asia Pacific
      • 5.2.4. India
      • 5.2.5. Africa
  6. 6. Global Malaria Diagnostics Industry Analysis, Insights and Forecast, 2021-2033
    • 6.1. Market Analysis, Insights and Forecast - by Technology
      • 6.1.1. Clinical Diagnostics
      • 6.1.2. Microscopic Diagnostics
      • 6.1.3. Rapid Diagnostic Tests (RDTs)
      • 6.1.4. Molecular Diagnostics
      • 6.1.5. Other Technologies
  7. 7. Americas Malaria Diagnostics Industry Analysis, Insights and Forecast, 2020-2032
    • 7.1. Market Analysis, Insights and Forecast - by Technology
      • 7.1.1. Clinical Diagnostics
      • 7.1.2. Microscopic Diagnostics
      • 7.1.3. Rapid Diagnostic Tests (RDTs)
      • 7.1.4. Molecular Diagnostics
      • 7.1.5. Other Technologies
  8. 8. Europe Malaria Diagnostics Industry Analysis, Insights and Forecast, 2020-2032
    • 8.1. Market Analysis, Insights and Forecast - by Technology
      • 8.1.1. Clinical Diagnostics
      • 8.1.2. Microscopic Diagnostics
      • 8.1.3. Rapid Diagnostic Tests (RDTs)
      • 8.1.4. Molecular Diagnostics
      • 8.1.5. Other Technologies
  9. 9. Asia Pacific Malaria Diagnostics Industry Analysis, Insights and Forecast, 2020-2032
    • 9.1. Market Analysis, Insights and Forecast - by Technology
      • 9.1.1. Clinical Diagnostics
      • 9.1.2. Microscopic Diagnostics
      • 9.1.3. Rapid Diagnostic Tests (RDTs)
      • 9.1.4. Molecular Diagnostics
      • 9.1.5. Other Technologies
  10. 10. India Malaria Diagnostics Industry Analysis, Insights and Forecast, 2020-2032
    • 10.1. Market Analysis, Insights and Forecast - by Technology
      • 10.1.1. Clinical Diagnostics
      • 10.1.2. Microscopic Diagnostics
      • 10.1.3. Rapid Diagnostic Tests (RDTs)
      • 10.1.4. Molecular Diagnostics
      • 10.1.5. Other Technologies
  11. 11. Africa Malaria Diagnostics Industry Analysis, Insights and Forecast, 2020-2032
    • 11.1. Market Analysis, Insights and Forecast - by Technology
      • 11.1.1. Clinical Diagnostics
      • 11.1.2. Microscopic Diagnostics
      • 11.1.3. Rapid Diagnostic Tests (RDTs)
      • 11.1.4. Molecular Diagnostics
      • 11.1.5. Other Technologies
  12. 12. Competitive Analysis
      • 12.1. Company Profiles
        • 12.1.1 AdvaCare Pharma*List Not Exhaustive
          • 12.1.1.1. Company Overview
          • 12.1.1.2. Products
          • 12.1.1.3. Company Financials
          • 12.1.1.4. SWOT Analysis
        • 12.1.2 BioMerieux SA
          • 12.1.2.1. Company Overview
          • 12.1.2.2. Products
          • 12.1.2.3. Company Financials
          • 12.1.2.4. SWOT Analysis
        • 12.1.3 Bio-Rad Laboratories Inc
          • 12.1.3.1. Company Overview
          • 12.1.3.2. Products
          • 12.1.3.3. Company Financials
          • 12.1.3.4. SWOT Analysis
        • 12.1.4 Nikon Corporation
          • 12.1.4.1. Company Overview
          • 12.1.4.2. Products
          • 12.1.4.3. Company Financials
          • 12.1.4.4. SWOT Analysis
        • 12.1.5 Siemens Healthineers
          • 12.1.5.1. Company Overview
          • 12.1.5.2. Products
          • 12.1.5.3. Company Financials
          • 12.1.5.4. SWOT Analysis
        • 12.1.6 Abbott Laboratories
          • 12.1.6.1. Company Overview
          • 12.1.6.2. Products
          • 12.1.6.3. Company Financials
          • 12.1.6.4. SWOT Analysis
        • 12.1.7 Ortho Clinical Diagnostics
          • 12.1.7.1. Company Overview
          • 12.1.7.2. Products
          • 12.1.7.3. Company Financials
          • 12.1.7.4. SWOT Analysis
        • 12.1.8 Premier Medical Corporation Pvt Ltd
          • 12.1.8.1. Company Overview
          • 12.1.8.2. Products
          • 12.1.8.3. Company Financials
          • 12.1.8.4. SWOT Analysis
        • 12.1.9 Advy Chemical Pvt Ltd
          • 12.1.9.1. Company Overview
          • 12.1.9.2. Products
          • 12.1.9.3. Company Financials
          • 12.1.9.4. SWOT Analysis
        • 12.1.10 Zephyr Biomedicals
          • 12.1.10.1. Company Overview
          • 12.1.10.2. Products
          • 12.1.10.3. Company Financials
          • 12.1.10.4. SWOT Analysis
        • 12.1.11 Access Bio Inc
          • 12.1.11.1. Company Overview
          • 12.1.11.2. Products
          • 12.1.11.3. Company Financials
          • 12.1.11.4. SWOT Analysis
        • 12.1.12 Thermo Fisher Scientific
          • 12.1.12.1. Company Overview
          • 12.1.12.2. Products
          • 12.1.12.3. Company Financials
          • 12.1.12.4. SWOT Analysis
      • 12.2. Market Entropy
        • 12.2.1 Company's Key Areas Served
        • 12.2.2 Recent Developments
      • 12.3. Company Market Share Analysis 2025
        • 12.3.1 Top 5 Companies Market Share Analysis
        • 12.3.2 Top 3 Companies Market Share Analysis
    • 12.4. List of Potential Customers
  13. 13. Research Methodology

    List of Figures

    1. Figure 1: Global Malaria Diagnostics Industry Revenue Breakdown (Million, %) by Region 2025 & 2033
    2. Figure 2: Americas Malaria Diagnostics Industry Revenue (Million), by Technology 2025 & 2033
    3. Figure 3: Americas Malaria Diagnostics Industry Revenue Share (%), by Technology 2025 & 2033
    4. Figure 4: Americas Malaria Diagnostics Industry Revenue (Million), by Country 2025 & 2033
    5. Figure 5: Americas Malaria Diagnostics Industry Revenue Share (%), by Country 2025 & 2033
    6. Figure 6: Europe Malaria Diagnostics Industry Revenue (Million), by Technology 2025 & 2033
    7. Figure 7: Europe Malaria Diagnostics Industry Revenue Share (%), by Technology 2025 & 2033
    8. Figure 8: Europe Malaria Diagnostics Industry Revenue (Million), by Country 2025 & 2033
    9. Figure 9: Europe Malaria Diagnostics Industry Revenue Share (%), by Country 2025 & 2033
    10. Figure 10: Asia Pacific Malaria Diagnostics Industry Revenue (Million), by Technology 2025 & 2033
    11. Figure 11: Asia Pacific Malaria Diagnostics Industry Revenue Share (%), by Technology 2025 & 2033
    12. Figure 12: Asia Pacific Malaria Diagnostics Industry Revenue (Million), by Country 2025 & 2033
    13. Figure 13: Asia Pacific Malaria Diagnostics Industry Revenue Share (%), by Country 2025 & 2033
    14. Figure 14: India Malaria Diagnostics Industry Revenue (Million), by Technology 2025 & 2033
    15. Figure 15: India Malaria Diagnostics Industry Revenue Share (%), by Technology 2025 & 2033
    16. Figure 16: India Malaria Diagnostics Industry Revenue (Million), by Country 2025 & 2033
    17. Figure 17: India Malaria Diagnostics Industry Revenue Share (%), by Country 2025 & 2033
    18. Figure 18: Africa Malaria Diagnostics Industry Revenue (Million), by Technology 2025 & 2033
    19. Figure 19: Africa Malaria Diagnostics Industry Revenue Share (%), by Technology 2025 & 2033
    20. Figure 20: Africa Malaria Diagnostics Industry Revenue (Million), by Country 2025 & 2033
    21. Figure 21: Africa Malaria Diagnostics Industry Revenue Share (%), by Country 2025 & 2033

    List of Tables

    1. Table 1: Global Malaria Diagnostics Industry Revenue Million Forecast, by Technology 2020 & 2033
    2. Table 2: Global Malaria Diagnostics Industry Revenue Million Forecast, by Region 2020 & 2033
    3. Table 3: Global Malaria Diagnostics Industry Revenue Million Forecast, by Technology 2020 & 2033
    4. Table 4: Global Malaria Diagnostics Industry Revenue Million Forecast, by Country 2020 & 2033
    5. Table 5: Venezuela Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    6. Table 6: Brazil Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    7. Table 7: Colombia Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    8. Table 8: Rest of the Americas Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    9. Table 9: Global Malaria Diagnostics Industry Revenue Million Forecast, by Technology 2020 & 2033
    10. Table 10: Global Malaria Diagnostics Industry Revenue Million Forecast, by Country 2020 & 2033
    11. Table 11: Germany Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    12. Table 12: United Kingdom Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    13. Table 13: France Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    14. Table 14: Turkey Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    15. Table 15: Spain Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    16. Table 16: Rest of Europe Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    17. Table 17: Global Malaria Diagnostics Industry Revenue Million Forecast, by Technology 2020 & 2033
    18. Table 18: Global Malaria Diagnostics Industry Revenue Million Forecast, by Country 2020 & 2033
    19. Table 19: Global Malaria Diagnostics Industry Revenue Million Forecast, by Technology 2020 & 2033
    20. Table 20: Global Malaria Diagnostics Industry Revenue Million Forecast, by Country 2020 & 2033
    21. Table 21: Myanmar Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    22. Table 22: Indonesia Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    23. Table 23: Pakistan Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    24. Table 24: China Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    25. Table 25: Papua New Guinea Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    26. Table 26: Cambodia Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    27. Table 27: Rest of Asia Pacific Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    28. Table 28: Global Malaria Diagnostics Industry Revenue Million Forecast, by Technology 2020 & 2033
    29. Table 29: Global Malaria Diagnostics Industry Revenue Million Forecast, by Country 2020 & 2033
    30. Table 30: Democratic Republic of Congo Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    31. Table 31: Nigeria Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    32. Table 32: Uganda Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033
    33. Table 33: Rest of Africa Malaria Diagnostics Industry Revenue (Million) Forecast, by Application 2020 & 2033

    Frequently Asked Questions

    1. What is the projected Compound Annual Growth Rate (CAGR) of the Malaria Diagnostics Industry?

    The projected CAGR is approximately 5.23%.

    2. Which companies are prominent players in the Malaria Diagnostics Industry?

    Key companies in the market include AdvaCare Pharma*List Not Exhaustive, BioMerieux SA, Bio-Rad Laboratories Inc, Nikon Corporation, Siemens Healthineers, Abbott Laboratories, Ortho Clinical Diagnostics, Premier Medical Corporation Pvt Ltd, Advy Chemical Pvt Ltd, Zephyr Biomedicals, Access Bio Inc, Thermo Fisher Scientific.

    3. What are the main segments of the Malaria Diagnostics Industry?

    The market segments include Technology.

    4. Can you provide details about the market size?

    The market size is estimated to be USD 0.86 Million as of 2022.

    5. What are some drivers contributing to market growth?

    Growing Demand for Diagnostic Tools in Malaria-endemic Regions; Increasing Technological Advancements and Efficient Diagnostics; Scale-up of Rapid Diagnostic Tests and Universal Access to Diagnosis.

    6. What are the notable trends driving market growth?

    Microscopic Diagnostics is Expected to Hold the Highest Market Share in the Technology Segment.

    7. Are there any restraints impacting market growth?

    Increasing Number of Malaria-free Countries; Rising Demand for Low-cost Diagnostic Tools.

    8. Can you provide examples of recent developments in the market?

    In June 2022, SC Johnson and Global Fund partnered to eradicate malaria. The Global Fund provides 56% of all international financing for malaria programs (39% of total available resources) and invested more than USD 16 billion in malaria control programs to date.

    9. What pricing options are available for accessing the report?

    Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.

    10. Is the market size provided in terms of value or volume?

    The market size is provided in terms of value, measured in Million.

    11. Are there any specific market keywords associated with the report?

    Yes, the market keyword associated with the report is "Malaria Diagnostics Industry," which aids in identifying and referencing the specific market segment covered.

    12. How do I determine which pricing option suits my needs best?

    The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

    13. Are there any additional resources or data provided in the Malaria Diagnostics Industry report?

    While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

    14. How can I stay updated on further developments or reports in the Malaria Diagnostics Industry?

    To stay informed about further developments, trends, and reports in the Malaria Diagnostics Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

    Methodology

    Step 1 - Identification of Relevant Samples Size from Population Database

    Step Chart
    Bar Chart
    Method Chart

    Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

    Approach Chart
    Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

    Note*: In applicable scenarios

    Step 3 - Data Sources

    Primary Research

    • Web Analytics
    • Survey Reports
    • Research Institute
    • Latest Research Reports
    • Opinion Leaders

    Secondary Research

    • Annual Reports
    • White Paper
    • Latest Press Release
    • Industry Association
    • Paid Database
    • Investor Presentations
    Analyst Chart

    Step 4 - Data Triangulation

    Involves using different sources of information in order to increase the validity of a study

    These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

    Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

    During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

    Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.